Lu Hongbo's Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Sep 17, 2024
- Accession no.
- 0000919574-24-005529
- Filed
- Sep 17, 2024
- Trade date
- Sep 12, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $5.00M. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lu HongboCIK 0001767584 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Common Stock | PPurchaseAcquired | +190,476 | $10.50 | +$1,999,998 | 190,476 | Indirect | |
| Sep 12, 2024 | Common Stock | PPurchaseAcquired | +285,714 | $10.50 | +$2,999,997 | 476,190 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.